Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae051 ↗Kurz gefasst
Editorial in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Ashraf Yusuf Rangrez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Heart Failure, Colorectal Neoplasms, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: German Research Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Förderung
- German Research Foundation
Zitieren
APA
Rangrez, A. Y., & Frey, N. (2024). Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae051
Vancouver
Rangrez AY, Frey N. Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae051
BibTeX
@article{Rangrez2024,
author = {Rangrez, Ashraf Yusuf and Frey, Norbert},
title = {Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae051}
}
EUVIMED